These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1638923)

  • 1. Molecular pharmacology of cocaine: a dopamine hypothesis and its implications.
    Kuhar MJ
    Ciba Found Symp; 1992; 166():81-9; discussion 89-95. PubMed ID: 1638923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter.
    Carroll FI; Lewin AH; Boja JW; Kuhar MJ
    J Med Chem; 1992 Mar; 35(6):969-81. PubMed ID: 1552510
    [No Abstract]   [Full Text] [Related]  

  • 3. The dopamine hypothesis of the reinforcing properties of cocaine.
    Kuhar MJ; Ritz MC; Boja JW
    Trends Neurosci; 1991 Jul; 14(7):299-302. PubMed ID: 1719677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909.
    Pögün S; Scheffel U; Kuhar MJ
    Eur J Pharmacol; 1991 Jun; 198(2-3):203-5. PubMed ID: 1864307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U; Pögün S; Stathis M; Boja JW; Kuhar MJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):954-8. PubMed ID: 2046028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselectivity of cocaine recognition sites: binding of (1S)- and (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane (beta-CIT) to monoamine transporters.
    Wang S; Gao Y; Laruelle M; Baldwin RM; Scanley BE; Innis RB; Neumeyer JL
    J Med Chem; 1993 Jun; 36(13):1914-7. PubMed ID: 8515428
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.
    Howell LL; Wilcox KM
    J Pharmacol Exp Ther; 2001 Jul; 298(1):1-6. PubMed ID: 11408518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
    Woolverton WL; Wang Z
    Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isopropyl and phenyl esters of 3 beta-(4-substituted phenyl)tropan-2 beta-carboxylic acids. Potent and selective compounds for the dopamine transporter.
    Carroll FI; Abraham P; Lewin AH; Parham KA; Boja JW; Kuhar M
    J Med Chem; 1992 Jun; 35(13):2497-500. PubMed ID: 1619622
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of a single dopamine transporter cDNA can confer two cocaine binding sites.
    Boja JW; Markham L; Patel A; Uhl G; Kuhar MJ
    Neuroreport; 1992 Mar; 3(3):247-8. PubMed ID: 1515577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of substituted 3-carbamoylecgonine methyl ester analogues: irreversible and photoaffinity ligands for the cocaine receptor/dopamine transporter.
    Kline RH; Eshleman AJ; Wright J; Eldefrawi ME
    J Med Chem; 1994 Jul; 37(14):2249-52. PubMed ID: 8035432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
    Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
    Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and dopamine transporter affinity of 2-(methoxycarbonyl)-9-methyl-3-phenyl-9-azabicyclo[3.3.1]nonane derivatives.
    Chen Z; Izenwasser S; Katz JL; Zhu N; Klein CL; Trudell ML
    J Med Chem; 1996 Nov; 39(24):4744-9. PubMed ID: 8941387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
    Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
    Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
    Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
    Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
    Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and function of the dopamine transporter.
    Chen N; Reith ME
    Eur J Pharmacol; 2000 Sep; 405(1-3):329-39. PubMed ID: 11033338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2'-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding.
    Seale TW; Avor K; Singh S; Hall N; Chan HM; Basmadjian GP
    Neuroreport; 1997 Nov; 8(16):3571-5. PubMed ID: 9427328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.